The ???Uber of Biotech??? Gets Back To Work

Hilary Kramer discusses biotech stocks, outlines their risks and compares the industry leader to Uber.

  • by:
  • 08/21/2022
ad-image

By Hilary Kramer

Forget the ???FANG??? group of the biggest technology companies. When you want pure disruptive innovation and a wild Wall Street ride, biotech remains the place to be.

I love these stocks. When they???re rallying, they???re a play on pure innovation. This is because they generate wealth for shareholders on what boils down to the confidence that medical science will keep advancing.

The upside is practically infinite. After all, most computer tools only improve life in increments, make us a little more productive day by day and expand our existing reach.

Biotech, at its most visionary, saves human lives that otherwise would be cut short one way or another. That transcends normal valuations.

Companies that develop those therapies can one day be worth the price of progress itself. And when that mood catches on, the stocks soar.

We???ve seen a few of these stocks on my Turbo Trader list soar 50 percent year to date. That???s true transformative upside. It???s exhilarating.

Click here to read more.

Image:

Opinion

View All

Flying Union Jack flag branded as ‘tool of hate' in leaked UK gov docs: report

The draft is part of an initiative that would see roughly £800million over the course of ten years al...

BBC alters Pete Hegseth speech, false translation suggests US targeting Iranian 'people'

The broadcaster made it appear as though Hegseth said the US was targeting the Iranian “people” rathe...

China cools off on military action near Taiwan ahead of Trump meeting with Xi

The move by Chinese President Xi Jinping may be in preparation ahead of a summit with President Donal...

DAVID KRAYDEN: Mark Carney is performing a tight-rope act between backing the US and angering Liberal, Arab voters

Carney is now inching towards a direct military commitment even though doing so will almost certainly...